The neuroendocrine paradox is that higher VEGF concentrations in benign pancreatic neuroendocrine neoplasms (pNENs) are associated with a good prognosis, as vessel density determines the rate of differentiation rather than tumor aggressiveness [15,25]. This evidence concerns the gene VEGFA and neoplasm.